Santhera Pharmaceuticals AG (SANN.SW) Eyes Approval of Lead Drug, Catena in First Half of 2011  
6/16/2010 7:00:01 AM

Reuters -- Swiss Santhera is aiming to seek approval for lead drug Catena to treat a rare eye disease in the first half of 2011 after a trial showed it improved sight, boosting the biotech group's prospects.